Ibere PharmaceuticalsNYSE IBER Stock Report

Ibere Pharmaceuticals is a blank check company, which was formed in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2021-02-26. The firm is created for the purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm focuses on healthcare sector. The firm has no operations and has not generated revenues.